Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Masimo Corp MASI

Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital... see more

Recent & Breaking News (NDAQ:MASI)

Study Investigates the Utility of Masimo ORi(TM), Oxygen Reserve Index, to Reduce Hyperoxia in Critically Ill Patients

Business Wire August 26, 2019

Masimo Announces Investment in Pulmonary Care Company TNI medical AG

Business Wire August 15, 2019

Study Demonstrates Reduction in Mortality Using Masimo Noninvasive, Continuous Hemoglobin (SpHb®) and Pleth Variability Index (PVi®) Monitoring

Business Wire August 7, 2019

Masimo Announces CE Marking of Neonatal Indication for Noninvasive, Continuous Hemoglobin Monitoring (SpHb®)

Business Wire August 5, 2019

Masimo Reports Second Quarter 2019 Financial Results

Business Wire July 31, 2019

Study Investigates the Ability of Continuous Noninvasive Hemoglobin Monitoring with Masimo SpHb® to Reflect Acute Hemodilution During Incremental Fluid Administration

Business Wire July 22, 2019

Masimo to Report Second Quarter 2019 Financial Results after Market Close on Wednesday, July 31

Business Wire July 17, 2019

New Study Investigates the Utility of Masimo ORi(TM), Oxygen Reserve Index, As an Indicator to Avoid Hyperoxia During General Anesthesia

Business Wire July 15, 2019

New Study Uses Masimo SedLine® Brain Function Monitoring to Assess the Prevalence of Isoelectric EEG Events in Infants and Young Children Undergoing General Anesthesia

Business Wire June 24, 2019

Masimo Announces FDA Clearance of Neonatal Indication for O3® Regional Oximetry

Business Wire June 10, 2019

NuVision Management Healthcare Consulting Company, One of the Largest U.S. Providers of Long-term Care for Medically Complex Children, Converts to Masimo

Business Wire May 28, 2019

New Study Evaluates Ability of Masimo SpHb® (Noninvasive Hemoglobin) to Estimate Timing for Invasive Measurement to Detect Anemia During Surgery

Business Wire May 20, 2019

Masimo to Present at UBS Global Healthcare Conference

Business Wire May 14, 2019

Masimo and Mindray Announce Expanded Partnership

Business Wire May 13, 2019

Masimo Reports First Quarter 2019 Financial Results

Business Wire May 6, 2019

Masimo Announces Halo ION(TM)

Business Wire April 30, 2019

Masimo Announces First CE-marked Third-party Masimo Open Connect® Module for the Root® Patient Monitoring and Connectivity Hub

Business Wire April 29, 2019

Masimo to Report First Quarter 2019 Financial Results after Market Close on Monday, May 6

Business Wire April 22, 2019

New Study Investigates Cerebral Oxygenation Normative Values Using Masimo O3® Regional Oximetry

Business Wire April 15, 2019

Masimo to Present at 18th Annual Needham Healthcare Conference

Business Wire April 2, 2019